C-Mer Eye Care's H1 revenue rises, net profit flat

C-Mer Medical Holdings

25/08/2026 13:52

Overview
Eye care provider's revenue rose 8.5% yr/yr for six months ended June
Net profit attributable to equity holders increased 0.2% yr/yr
Adjusted profit for the period declined, net profit margin fell to 5.6%

Outlook
Company did not provide specific guidance or outlook for the current or future periods

Result Drivers
MAINLAND CHINA EYE DEMAND – Ophthalmic-services revenue rose 3.0% to HK$631.4 mln, primarily driven by increased demand in Mainland China
SHENZHEN DENTAL BRAND – Dental-services revenue rose 19.0% to HK$282.5 mln, mainly due to stronger brand recognition for Shenzhen CKJ

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
HK$1.02 bln
 
H1 Net Income Attributable
 
HK$50.02 mln
 

Analyst Coverage
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 14 three months ago

Reuters Recommended Reads
Aug 24 - China's Shanghai INT Medical Instruments H1 revenue jumps on acquisitions
Aug 24 - China's Peijia Medical H1 revenue jumps on transcatheter valve therapeutics growth
Aug 24 - Sinopharm interim revenue edges down on softness in pharmaceutical distribution business

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)